A multi-centre study comparing idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema

Idiopathic pulmonary fibrosis with or without emphysema: a 3-year multi-centre study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN28134901

Enrollment

250

Registered

2023-08-13

Start date

2018-08-01

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with interstitial pulmonary fibrosis only (IPF) and patients with combined pulmonary fibrosis and emphysema (CPFE) Respiratory

Interventions

The study involved following IPF and CPFE patients for a duration of 3 years and recording their survival outcomes.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with a definitive diagnosis of interstitial lung disease by a pulmonologist and confirmed by high-resolution computed tomography (HRCT) 2. Passed the health insurance review to pay for the anti-pulmonary fibrosis medications

Exclusion criteria

Exclusion criteria: 1. Patients not fulfilling the criteria of interstitial lung disease 2. Patients not having health insurance to cover anti-fibrotic medications

Design outcomes

Primary

Measure	Time frame
3-year survival rate measured using patients' medical records	—

Secondary

Measure	Time frame
1. Pulmonary function measured using spirometer at baseline and every year for 3 years 2. Disease progression measured using Gender-Age-Physiology (GAP) score at baseline and every year for 3 years	—

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026